Multiple Sclerosis Clinical Trial

Nomad P-KAFO Study

Summary

The goal of this clinical trial is to evaluate the impact of using the Nomad powered KAFO in people who have had a musculoskeletal or neurological injury that has affected their ability to walk. The main questions it aims to answer are to quantify the effectiveness of the Nomad in improving mobility, balance, frequency of falls, and quality of life in individuals with lower-extremity impairments compared to their own brace, over three months of daily home and community use.

Participants will:

Wear a sensor that records everyday activities and mobility.
Perform measures of mobility and different activities of participation using their own brace.
Perform measures of mobility and different activities of participation using the Nomad powered KAFO

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Regular and compliant use of a unilateral or bilateral KAFO or SCO or other passive KAFOs for impairment due to neurological or neuromuscular disease, orthopedic disease, or trauma
Cognitive ability to understand and follow the study protocol; willingness to provide informed consent
Willing to wear and charge an activity monitor for three-months home trials.

Exclusion Criteria:

Flexion contracture in the knee and/or hip joint in excess of 15 degrees
Non-correctable knee varus/valgus in excess of 15 degrees
Severe spasticity
Inability to stabilize the trunk with or without assistive devices (crutches, canes, etc.)

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

36

Study ID:

NCT05644522

Recruitment Status:

Recruiting

Sponsor:

Shirley Ryan AbilityLab

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Shirley Ryan AbilityLab
Chicago Illinois, 60611, United States More Info
Arun Jayaraman, PhD
Contact
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

36

Study ID:

NCT05644522

Recruitment Status:

Recruiting

Sponsor:


Shirley Ryan AbilityLab

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.